1247897-89-7

Basic information

• Product Name: {1-[4-(3-bromo-6-phenyl-imidazo[1,2-a]pyrimidin-7-yl)phenyl]cyclobutyl}carbamic acid tert-butyl ester
• Synonyms: {1-[4-(3-bromo-6-phenyl-imidazo[1,2-a]pyrimidin-7-yl)phenyl]cyclobutyl}carbamic acid tert-butyl ester
• CAS NO: 1247897-89-7
• Molecular Weight: 519.441
• Mol File: 1247897-89-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: {1-[4-(3-bromo-6-phenyl-imidazo[1,2-a]pyrimidin-7-yl)phenyl]cyclobutyl}carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: {1-[4-(3-bromo-6-phenyl-imidazo[1,2-a]pyrimidin-7-yl)phenyl]cyclobutyl}carbamic acid tert-butyl ester(1247897-89-7)
• EPA Substance Registry System: {1-[4-(3-bromo-6-phenyl-imidazo[1,2-a]pyrimidin-7-yl)phenyl]cyclobutyl}carbamic acid tert-butyl ester(1247897-89-7)

Safety Data

• Hazardous Substances Data: 1247897-89-7(Hazardous Substances Data)

Upstream product

• 1247897-86-4 {1-[4-(6-phenyl-imidazo[1,2-a]pyrimidin-7-yl)phenyl]cyclobutyl}carbamic acid tert-butyl ester 
• 1193389-40-0 1-(4-bromophenyl)cyclobutane-1-amine hydrochloride 
• 1094218-30-0 1-(4-bromophenyl)cyclobutanamine 
• 1116116-40-5 7-chloro-6-phenylimidazo[1,2-a]pyrimidine 
• 1032528-06-5 {1-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclobutyl}-carbamic acid tert.-butyl ester 
• 1032350-06-3 tert-butyl (1-(4-bromophenyl)cyclobutyl)carbamate 
• 502506-57-2 6-phenylimidazo[1,2-a]pyrimidine-5,7-diol 
• 502506-42-5 5,7-dichloro-6-phenylimidazo[1,2-a]pyrimidine 
• 83-13-6 diethyl 2-phenylmalonate 

Downstream Products

• 1355240-85-5 (1-{4-[3-(4-fluorophenyl)-6-phenyl-imidazo[1,2-a]pyrimidin-7-yl]phenyl}cyclobutyl)carbamic acid tert-butyl ester 
• 1355240-89-9 (1-{4-[3-(4-methanesulfonyl-phenyl)-6-phenyl-imidazo[1,2-a]pyrimidin-7-yl]phenyl}cyclobutyl)carbamic acid tert-butyl ester 
• 1355240-23-1 1-{4-[3-(4-fluorophenyl)-6-phenyl-imidazo[1,2-a]pyrimidin-7-yl]phenyl}cyclobutylamine 

Relevant articles and documents

BICYCLIC PYRIMIDINES

Compounds of formula (I), which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.